跳至主要内容
临床试验/CTRI/2023/08/056028
CTRI/2023/08/056028招募中3 期

Comparative efficacy and safety assessment of tadalafil plus finasteride versus tadalafil plus dutasteride in treatment of lower urinary tract symptoms in benign prostatic hyperplasia. - NI

Pt B.D. Sharma UHS Rohtak0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients above 65 years of age.
  • 2. History of lower urinary tract symptoms/benign prostatic hyperplasia for the last 6 months.
  • 3. International Prostate Symptom Score = 13.
  • 4. Prostate volume = 30 ml.

排除标准

  • 1. Patients having hypertension, coronary artery disease, cardiac arrhythmias.
  • 2. Patients diagnosed as a case of carcinoma prostate.
  • 3. Patients with hepatic function impairment.

研究者

发起方
Pt B.D. Sharma UHS Rohtak

相似试验